Pharma Services

HTG Molecular partners with pharmaceutical clients by offering a suite of comprehensive services for biomarker discovery and companion diagnostic (CDx) development. Using clinical source material, HTG Molecular’s innovative gene expression technology enables signature discovery efforts and the development of diagnostic content, ultimately facilitating the delivery of personalized healthcare. HTG Molecular assists in the identification of traditional and novel RNA-based biomarkers and the development of high value clinical assays.

HTG Molecular’s CDx co-development program positions its strength in laboratory developed tests to efficiently reduce risk by removing delays in the drug development and approval process. Partnership programs include a wide range of services and solutions customized for the needs of pharmaceutical and biotech clients.